BioAdaptives, Inc. announced the Company's formation of TizHemp, a new operating division to concentrate efforts on wellness-related hemp-based products, and the appointment of Mr. Ron Lambrecht as the Company's new Chief Financial Officer, reporting to the CEO, President, and Board, effective 1 October, 2019. For the past 25 years Mr. Lambrecht has operated a financial services business in addition to facilitating a number of technology acquisitions and joint venture transactions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | 0.00% | +20.00% | +20.00% |
May. 17 | BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+20.00% | 739K | |
+15.09% | 8.35B | |
+3.37% | 7.62B | |
+1.45% | 6.01B | |
-6.26% | 3.75B | |
-9.86% | 3.7B | |
-6.55% | 1.34B | |
-28.83% | 1.13B | |
+14.31% | 992M | |
-10.78% | 925M |
- Stock Market
- Equities
- BDPT Stock
- News BioAdaptives, Inc.
- BioAdaptives, Inc. Announces Tizhemp, a New Hemp-Product Division; Appoints Ron Lambrecht as New CFO